Ace inhibitors
Pro Research Analysisby 
Searched over 200M research papers for "ace inhibitors"
Mechanism of Action and Clinical Uses of ACE Inhibitors
Angiotensin-converting enzyme (ACE) inhibitors are a major class of drugs used to manage hypertension, heart failure, and chronic kidney disease. They work by blocking the conversion of angiotensin I to angiotensin II, a hormone that causes blood vessels to constrict and raises blood pressure. By inhibiting this process, ACE inhibitors cause blood vessels to relax, reduce blood volume, and lower blood pressure, which helps prevent and treat cardiovascular and kidney diseases 289. Additionally, ACE inhibitors increase bradykinin levels, a vasodilator, further contributing to their blood pressure-lowering effects 29.
Side Effects and Safety Considerations of ACE Inhibitors
While ACE inhibitors are effective and widely used, they are associated with certain side effects. The most notable are cough and angioedema, both linked to increased bradykinin levels. Angioedema, though rare (0.1–0.7% incidence), can be serious and is more common in African Americans, smokers, women, older adults, and those with certain medical histories. Patients who experience ACE inhibitor-induced angioedema should not be re-exposed to these drugs due to the risk of recurrence 39. Compared to angiotensin receptor blockers (ARBs), ACE inhibitors have a higher risk of these bradykinin-mediated side effects, while ARBs offer similar blood pressure control with improved tolerability .
Advances in ACE Inhibitor Design and Structural Insights
Recent advances in structural biology, including high-resolution crystallography and cryo-electron microscopy, have provided detailed insights into how ACE inhibitors interact with the enzyme. These studies have revealed the structure of ACE’s active sites and the mechanisms of inhibitor binding, which are crucial for designing more selective and effective drugs with fewer side effects. Computational modeling and molecular docking have further aided the development of next-generation ACE inhibitors, including allosteric inhibitors that may offer improved safety and efficacy 258.
Natural and Food-Derived ACE Inhibitors
Research has identified several natural ACE inhibitory peptides from food sources such as foxtail millet, soybean, whey protein, and marine algae. These peptides have shown strong ACE inhibitory activity in laboratory studies and are considered non-toxic, with some maintaining their activity even after digestion. Their mechanisms often involve binding to ACE’s active sites through hydrogen bonds and hydrophobic interactions, similar to pharmaceutical ACE inhibitors. These findings suggest that food-derived peptides could be developed into functional foods or supplements for blood pressure management 1467.
Metabolic Benefits Beyond Blood Pressure Control
ACE inhibitors may also improve metabolic control, particularly in people with insulin resistance or type 2 diabetes. They can enhance glucose uptake in skeletal muscle by increasing bradykinin-mediated nitric oxide production and reducing the inhibitory effects of angiotensin II on glucose transport. Chronic use of ACE inhibitors has been shown to upregulate insulin signaling pathways and increase glucose transporter expression, supporting their beneficial role in metabolic health .
Conclusion
ACE inhibitors are a cornerstone in the treatment of hypertension and related conditions, offering effective blood pressure control and additional metabolic benefits. Ongoing research is focused on improving their safety and efficacy through better drug design and exploring natural alternatives from food sources. While generally well-tolerated, clinicians must be mindful of side effects like cough and angioedema, and consider patient-specific risk factors when prescribing these medications.
Sources and full results
Most relevant research papers on this topic